Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery

Journal of Biomedical Nanotechnology

Volumn 6, Issue 6, 2010, Pages 675-682

  Liu, Donghua ^a   Wang, Lili ^a   Liu, Zhihong ^a   Zhang, Cai ^a   Zhang, Na ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cytotoxicity; Docetaxel; Nanoparticles; Poly(lactic acid) Poly(ethylene glycol) Copolymer (PLA PEG)

Indexed keywords

A549 CELLS; APOPTOSIS; DOCETAXEL; DRUG DELIVERY SYSTEM; DRUG LOADING; DRUG SOLUBILITY; ENTRAPMENT EFFICIENCY; HEPATOCELLULAR; HOECHST; HUMAN CANCER CELLS; IN-VITRO; IN-VITRO EVALUATION; MEAN DIAMETER; PLA-PEG; POLY(LACTIC ACID); POLY(LACTIC ACID)-POLY(ETHYLENE GLYCOL) COPOLYMER (PLA-PEG); SIDE EFFECT; TWEEN 80; WEIBULL;

BODY FLUIDS; CELL CULTURE; CELL DEATH; COPOLYMERIZATION; COPOLYMERS; CYTOTOXICITY; DRUG DELIVERY; DRUG PRODUCTS; ETHYLENE; ETHYLENE GLYCOL; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE ANALYSIS; POLYETHYLENE OXIDES; SOLUBILITY; ZETA POTENTIAL;

POLYETHYLENE GLYCOLS;

DOCETAXEL; DOCETAXEL LOADED POLY(LACTIC ACID) POLY(ETHYLENEGLYCOL); DUOPAFEI; MACROGOL; NANOPARTICLE; POLYLACTIC ACID; SOLVENT; UNCLASSIFIED DRUG; LACTIC ACID; MACROGOL DERIVATIVE; POLYMER; TAXOID;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; ENCAPSULATION; FREEZE DRYING; HUMAN; HUMAN CELL; PARTICLE SIZE; REACTION ANALYSIS; VOLATILIZATION; ZETA POTENTIAL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; IC 50; INFUSION; SOLUBILITY; TUMOR CELL LINE;

CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; HUMANS; INFUSIONS, PARENTERAL; INHIBITORY CONCENTRATION 50; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMERS; SOLUBILITY; TAXOIDS;

EID: 79953003780     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2010.1160     Document Type: Article

References (41)

1. E. Saloustros and V. Georgoulias, Docetaxel in the treatment of advanced non-small-cell lung cancer. Expert. Rev. Anticancer. Ther. 8, 1207 (2008).
2. E. Saloustros, D. Mavroudis, and V. Georgoulias, Paclitaxel and docetaxel in the treatment of breast cancer. Expert. Opin. Pharmacother. 9, 2603 (2008).
3. N. K. Haass, K. Sproesser, T. K. Nguyen, R. Contractor, C. A. Medina, K. L. Nathanson, M. Herlyn, and K. S. Smalley, The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel. Clin. Cancer. Res. 14, 230 (2008).
4. H. Gelderblom, J. Verweij, K. Nooter, and A. Sparreboom, Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37, 1590 (2001).
5. P. E. Lonning, Study of suboptimum treatment response: Lessons from breast cancer. Lancet. Oncol. 4, 177 (2003).
6. R. Bi, W. Shao, Q. Wang, and N. Zhang, Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery. J. Biomed. Nanotechnol. 5, 84 (2009).
7. A. B. Sarkar, U. Kestur, and G. M. Kochak, Interfacially assembled carbohydrate nanocapsules: A hydrophilic macromolecule delivery platform. J. Biomed. Nanotechnol. 5, 456 (2009).
8. L. Jorgensen, S. Martins, and M. van de Weert, Analysis of protein physical stability in lipid based delivery systems - the challenges of lipid drug delivery systems. J. Biomed Nanotechnol. 5, 401 (2009).
9. D. J. Bharali, M. Khalil, M. Gurbuz, T. M. Simone, and S. A. Mousa, Nanoparticles and cancer therapy: A concise review with emphasis on dendrimers. Int. J. Nanomedicine 4, 1 (2009).
10. X. Liu, K. Nakamura, Y. Wang, D. Cheng, M. Liang, N. Xiao, L. Chen, M. Rusckowski, and D. J. Hnatowich, Auger-mediated cytotoxicity of cancer cells in culture by an 1251-antisense oligomer delivered as a three-component streptavidin nanoparticle. J. Biomed. Nanotechnol. 6, 153 (2010).
11. P. Wu, X. He, K. Wang, W. Tan, C. He, and M. Zheng, A novel methotrexate delivery system based on chitosan-methotrexate covalently conjugated nanoparticles. J. Biomed. Nanotechnol. 5, 557 (2009).
12. E. B. Souto, P. Martins-Lopes, C. M. Lopes, I. Gaivão, A. M Silva, and H. Guedes-Pinto, A note on regulatory concerns and toxicity assessment in lipid-based delivery systems (LDS), J. Biomed. Nano-technol. 5, 317 (2009).
13. P. Blasi, A. Schoubben, S. Giovagnoli, C. Rossi, and M. Ricci, Lipid nanoparticles for drug delivery to the brain: In vivo Veritas. J. Biomed. Nanotechnol. 5, 344 (2009).
14. K. Ruckmani, V. Sankar, and M. Sivakumar, Tissue distribution, pharmacokinetics and stability studies of zidovudine delivered by niosomes and proniosomes. J. Biomed. Nanotechnol. 6, 43 (2010).
15. R. Pasqualini, W. Arap, and D. M. McDonald, Probing the structural and molecular diversity of tumor vasculature. Trends. Mol. Med. 8, 563 (2002).
16. S. K. Hobbs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain, Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA 95, 4607 (1998).
17. F. M. Muggia, Doxorubicin-polymer conjugates: Further demonstration of the concept of enhanced permeability and retention. Clin. Cancer. Res. 5, 7 (1999).
18. H. Maeda, T. Sawa, and T. Konno, Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Controlled Release 74, 47 (2001).
19. N. Csaba, M. Köping-Höggård, E. Fernandez-Megia, R. Novoa-Carballal, R. Riguera, and M. J. Alonso, Ionically crosslinked chitosan nanoparticles as gene delivery systems: Effect of PEGylation degree on in vitro and in vivo gene transfer. J. Biomed. Nanotechnol. 5, 162 (2009).
20. G. Bhakta, A. Shrivastava, and A. Maitra, Magnesium phosphate nanoparticles can be efficiently used in vitro and in vivo as non-viral vectors for targeted gene delivery. J. Biomed. Nanotechnol. 5, 106 (2009).
21. X. Zhang, J. K. Jackson, and H. M. Burt, Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int. J. Pharm. 132, 195 (1996).
22. S. Zhou, X. Deng, and X. Li, Investigation on a novel core-coated microspheres protein delivery system, J. Controlled Release 75, 27 (2001).
23. W. Wang, S. Zhou, L. Guo, W. Zhi, X. Li, and J. Weng, Investigation of endocytosis and cytotoxicity of poly-d,1-lactide-poly(ethylene glycol) nano/micro-particles in osteoblast cells. Int. J. Nanomed. 5, 557 (2010).
24. K. Yasugi, Y. Nagasaki, M. Kato, and K. Kataoka, Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L- lactide) block copolymers as potential drug carrier. J. Controlled Release 62, 89 (1999).
25. H. Cabrai, N. Nishiyama, and K. Kataoka, Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity. J. Controlled Release 121, 146 (2007).
26. Z. L. Yang, X. R. Li, K. W. Yang, and Y. Liu, Amphotericin B-loaded poly(ethylene glycol)-poly(lactide) micelles: Preparation, freeze-drying, and in vitro release. J. Biomed. Mater. Res. 85, 539 (2008).
27. D. W. Kim, S. Y. Kim, H. K. Kim, S. W. Kim, S. W. Shin, J. S. Kim, K. Park, M. Y. Lee, and D. S. Heo, Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann. Oncol. 18, 2009 (2007).
28. J. C. Olivier, Drug transport to brain with targeted nanoparticles. NeuroRx. 2, 108 (2005).
29. F. Q. Hu, S. P. Jiang, Y Z. Du, H. Yuan, Y. Q. Ye, and S. Zeng, Preparation and characteristics of monostearin nanostructured lipid carriers. Int. J. Pharm. 314, 83 (2006).
30. N. Yanasarn, B. R. Sloat, and Z. Cui, Nanoparticles engineered from lecithin-in-water emulsions as a potential delivery system for docetaxel. Int. J. Pharm. 379, 174 (2009).
31. T. Mosmann, Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55 (1983).
32. Y. Yang, J. S. Jiang, B. Du, Z. F. Gan, M. Qian, and P. Zhang, Preparation and properties of a novel drug delivery system with both magnetic and biomolecular targeting. J. Mater. Sci. Mater. Med. 20, 301 (2009).
33. X. Sun, J. Zhang, L. Wang, and Z. Tian, Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN. Cancer Lett. 262, 201 (2008).
34. X. Wang, Y. Wang, X. Chen, J. Wang, X. Zhang, and Q. Zhang, NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells. J. Controlled Release 139, 56 (2009).
35. M. Pulkkinen, J. Pikkarainen, T. Wirth, T. Tarvainen, V. Haapa-aho, H. Korhonen, J. Seppälä, and K. Järvinen, Three-step tumor targeting of paclitaxel using biotinylated PLA-PEG nanoparticles and avidin-biotin technology: Formulation development and in vitro anticancer activity. Eur. J. Pharm. Biopharm. 70, 66 (2008).
36. H. L. Wong, A. M. Rauth, R. Bendayan, J. L. Manias, M. Ramaswamy, Z. Liu, S. Z. Erhan, and X. Y. Wu, A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm. Res. 23, 1574 (2006).
37. H. L. Wong, R. Bendayan, A. M. Rauth, H. Y. Xue, K. Babakhanian, and X. Y. Wu, A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J. Pharmacol. Exp. Ther. 317, 1372 (2006).
38. A. Montero, F. Fossella, G. Hortobagyi, and V. Valero, Docetaxel for treatment of solid tumours: A systematic review of clinical data. Lancet Oncol. 6, 229 (2005).
39. L. G. Wang, X. M. Liu, W. Kreis, and D. R. Budman, The effect of antimicrotubule agents on signal transduction pathways of apoptosis: A review. Cancer Chemother. Pharmacol. 44, 355 (1999).
40. D. L. Morse, H. Gray, C. M. Payne, and R. J. Gillies, Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol. Cancer Ther. 4, 1495 (2005).
41. X. Li, D. Wang, J. Zhang, and W. Pan, Preparation and pharmacokinetics of docetaxel based on nanostructured lipid carriers. J. Pharm. Pharmacol. 61, 1485 (2009).